| # | Drug | Count |
|---|---|---|
| 0 | CYCLOPHOSPHAMIDE | 17 |
| 1 | CYCLOPHOSPHAMIDE FOR INJECTION | 17 |
| 2 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 17 |
| 3 | BLINATUMOMAB | 16 |
| 4 | PREDNISONE | 14 |
| 5 | ABIRATERONE | 11 |
| 6 | ABIRATERONE ACETATE | 11 |
| 7 | LENALIDOMIDE | 11 |
| 8 | NAPROXEN | 11 |
| 9 | NAPROXEN SODIUM | 11 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | INTERLEUKIN-10 | 1 | 0.0028 |
| 1 | BLINATUMOMAB | 16 | 0.0015 |
| 2 | PEMIGATINIB | 1 | 0.0012 |
| 3 | NELARABINE | 1 | 0.0010 |
| 4 | THIOGUANINE | 1 | 0.0005 |
| 5 | INOTUZUMAB OZOGAMICIN | 1 | 0.0003 |
| 6 | MITOXANTRONE HYDROCHLORIDE | 2 | 0.0003 |
| 7 | MELPHALAN HYDROCHLORIDE | 8 | 0.0003 |
| 8 | MICAFUNGIN SODIUM | 2 | 0.0003 |
| 9 | DEFIBROTIDE SODIUM | 1 | 0.0003 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 33 |
| 1 | Alkylating Drug [EPC] | 20 |
| 2 | CD20-directed Cytolytic Antibody [EPC] | 11 |
| 3 | Nonsteroidal Anti-inflammatory Drug [EPC] | 11 |
| 4 | Thalidomide Analog [EPC] | 11 |
| 5 | Calcium Channel Blocker [EPC] | 10 |
| 6 | Dihydropyridine Calcium Channel Blocker [EPC] | 10 |
| 7 | Nucleoside Metabolic Inhibitor [EPC] | 10 |
| 8 | Proteasome Inhibitor [EPC] | 9 |
| 9 | Azole Antifungal [EPC] | 8 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CD22-directed Immunoconjugate [EPC] | 1 | 0.0003 |
| 1 | Echinocandin Antifungal [EPC] | 2 | 0.0002 |
| 2 | Osmotic Diuretic [EPC] | 1 | 0.0002 |
| 3 | BCL-2 Inhibitor [EPC] | 8 | 0.0001 |
| 4 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 2 | 0.0001 |
| 5 | Alkylating Drug [EPC] | 20 | 0.0001 |
| 6 | Proteasome Inhibitor [EPC] | 9 | 0.0001 |
| 7 | Topoisomerase Inhibitor [EPC] | 4 | 0.0001 |
| 8 | Azole Antifungal [EPC] | 8 | 0.0001 |
| 9 | Microtubule Inhibitor [EPC] | 8 | 0.0000 |